Clinical Trials Directory

Trials / Completed

CompletedNCT06509399

Care Package for Preventing Pressure Ulcers in ICU Patients

Evaluation of the Effectiveness of a Pressure Ulcers Prevention Care Package in the Intensive Care Unit

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
72 (actual)
Sponsor
Abant Izzet Baysal University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to evaluate the effectiveness of the care package (CP) developed to prevent pressure injury (PI) in patients in intensive care and to evaluate the effect of the training given to nurses on their knowledge levels and attitudes.

Detailed description

This experimental study was carried out in the anesthesia and reanimation intensive care unit of Düzce Atatürk State Hospital. The part with patients was completed with a total of 72 patients, 36 in the control group and 36 in the application group. The occurrence rate of PI was compared between the control group and the application group. In the section about nurses, no sample was selected and all 50 nurses working in intensive care were included in the study. Nurses' knowledge and attitudes about PI before and after the training were compared. Data were analyzed using a statistical program.

Conditions

Interventions

TypeNameDescription
OTHERcare packageBefore the patients in the application group started to be observed, the nurses working in the clinic were trained about the risk assessment, skin assessment, incontinence management, nutrition assessment, positioning, support surfaces and injuries caused by the devices in the BP content to be used in the prevention of IU. After the trainings given to the nurses were completed, care was given to the patients in the practice group in accordance with BP. In addition, patient information was collected from patient information files, nurse observation forms and hospital automation system. In the evaluation step, full compliance with the 7 compliance steps specified in the BP was sought. If any one of these parameters was incomplete, the others were considered as incomplete. The patients in the control group were followed up for 30 days until the determined number of patients was reached and their data were collected.

Timeline

Start date
2023-05-15
Primary completion
2023-09-15
Completion
2023-09-15
First posted
2024-07-19
Last updated
2024-07-19

Locations

2 sites across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06509399. Inclusion in this directory is not an endorsement.